Abbott Laboratories NZ Ltd, PO Box 11437, Manners Street, Wellington 6142. Ph: 0800 73 72 71

Useful links: HUMIRA Pen | HUMIRA Pre-filled syringe

IMPORTANT INFORMATION ABOUT HUMIRA Humira is a Prescription Medicine containing 40 mg adalimumab per syringe or pen. It is used for reducing the signs and symptoms and slowing the progression of joint damage in adult patients with moderate to severe rheumatoid arthritis, including patients with recently diagnosed moderate to severely active disease who have not received methotrexate. It also treats the signs and symptoms of moderate to severe psoriatic arthritis in patients where response to previous disease-modifying anti-rheumatic drugs has been inadequate. It also reduces the signs and symptoms in patients with active ankylosing spondylitis. Humira may also be used for the treatment of moderate to severe Crohn’s disease in adults to reduce the signs and symptoms of the disease, and to induce and maintain clinical remission in patients who have had an inadequate response to conventional therapies, or who have lost response to or are intolerant of infliximab. Humira also treats moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Humira is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged 4 years of age and older. Humira can be used alone or in combination with methotrexate.You should not start Humira if you have an infection, including an infection that is only in one place (such as an open cut or sore) or an infection that is in your whole body (such as the ’flu). Tell your doctor if you have a history of recurrent infections or other conditions that increase the risk of infections. Tell your doctor if you live(d) or have travelled to countries where there is more risk for certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may develop or become more severe if you take Humira. Tell your doctor if you have ever had Hepatitis B or been in contact with someone with Hepatitis B. Before starting Humira, your doctor should check you for signs and symptoms of tuberculosis (TB). Tell your doctor if you have ever had TB, or if you have been in close contact with someone with TB. If symptoms of TB (a dry cough that doesn’t go away, weight loss, fever, night sweats), or symptoms of any other infections appear during therapy, tell your doctor immediately. Tell your doctor if you experience any numbness or tingling, or have ever had a disease that affects your nervous system, like multiple sclerosis, or if you experience allergic reactions such as a severe rash, swollen face or difficulty breathing, or if you have liver or kidney problems, or chest pain. Check with your doctor before you receive any vaccine. Tell your doctor if you are taking anakinra or about any other medicines you are taking. You should tell your doctor if you are pregnant, become pregnant, or are thinking about becoming pregnant. The most common side effects of Humira are upper respiratory tract infection, headache, rash, urinary tract infection, weakness, injection site pain, injection site reactions, nausea and diarrhoea.In New Zealand, Humira is fully subsidised on Specialist Authority for rheumatoid arthritis, severe psoriatic arthritis, ankylosing spondylitis, severe Crohn’s disease and severe plaque psoriasis – special conditions apply. Humira is not reimbursed for juvenile idiopathic arthritis. Medicines have benefits, and some have risks. Always read the label and use strictly as directed. If symptoms continue, or you have side effects, consult your doctor, pharmacist or nurse. For further advice on your treatment, please discuss with your doctor. Normal doctor’s visit fees apply. Abbott Laboratories NZ Ltd. 4 Pacific Rise, Mt Wellington, Auckland. For further information, please call Freephone 0800 73 72 71. ® Registered Trademark